NMPA medical device registration requirements in China

China represents a vast market for medical devices, but its regulatory system can be difficult to navigate. A recent report published by China’s medical device regulator, National Medical Products Administration (NMPA), indicates that medical device approvals decreased by 38% in 2018 compared to 2017, possibly as a result of the depth and breadth of medical device regulatory changes underway in China. Manufacturers who are considering accessing this market will benefit from understanding the ever-changing regulatory landscape in the country.

In this free webinar, market experts Janet Zhang and Annika Chen will discuss key medical device registration requirements in China, including:

• The history and regulatory structure of the NMPA, formerly known as the China Food and Drug Administration (CFDA)
• The regulatory pathway for market access
• Recent initiatives to ease regulatory requirements for foreign manufacturers of medical devices
• Details on implementation of the NMPA’s new electronic medical device registration management (eRPS) system
• New Unique Device Identifier (UDI) requirements
• And more

This webinar was recorded on December 12, 2019.